Related references
Note: Only part of the references are listed.Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho et al.
GUT (2014)
Role of Hepatitis B Surface Antigen (HBsAg) in Identifying True Inactive HBsAg Carriers Infected With Genotype C Hepatitis B Virus
Sun Young Yim et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease
Ha Na Park et al.
LIVER INTERNATIONAL (2012)
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Ju Dong Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
Chuen-Fei Chen et al.
GASTROENTEROLOGY (2011)
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations with Normal Liver Histology
Jae Keun Lee et al.
HEPATOLOGY (2010)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
DNA-guided hepatitis B treatment, viral load is essential, but not sufficient
Rafael Barcena Marugan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea
SH Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Share Paper
